About me
Diagnochip is a Chilean joint stock company devoted to develop medical devices to test antibiotic sensitivity at the point of care attention.Since its inception in 2102 Diagnochip has been actively working on the development of a medical device and two technologies that allow to get antibiotic sensitivit results earlier than conventional methods.
Depending on the technology used we are able to get accurately results from 4 hours of incubation at the point of care attention.
The device at a prototype advanced stage has been tested in Europe, obtaining excelent results to identify urinary infection, high sensitivity scores for the most used antibiotic and a high performance to read easily the results.
Follow Us